Previous 10 | Next 10 |
ICON plc (ICLR) Q4 2018 Earnings Conference Call February 21, 2019 9:00 AM ET Company Participants Jonathan Curtain - Vice President, Corporate Finance & Investor Relations Brendan Brennan - Chief Financial Officer Steve Cutler - Chief Executive Officer Conference Call Par...
The following slide deck was published by Icon PLC in conjunction with their 2018 Q4 earnings Read more ...
PORTLAND, Ore. and CAMBRIDGE, Mass., Feb. 21, 2019 (GLOBE NEWSWIRE) -- MolecularMD Corporation, a molecular diagnostic specialty laboratory that enables the development and commercialisation of precision medicines in oncology, announced today that it has been acquired by ICON plc (N...
Icon (NASDAQ: ICLR ): Q4 GAAP EPS of $1.62 beats by $0.02 . More news on: Icon PLC, Earnings news and commentary, Healthcare stocks news, Read more ...
Highlights Record net business wins* in the quarter of $607 million, a book to bill of 1.25. Full year net business wins* of $2.4 billion, a net book to bill of 1.27. Record closing backlog* of $5.4 billion, an increase of 9.7% year on year. Quarter 4 reported revenue of $679....
A , ALB , ATR , AXTI , CAI , CAKE , CAR , CBLK , CDE , CECO , CHE , CLI , CONE , CPRT , CUTR , CYH , EIG , ES , ESRT , ET , EVTC , EXR , FLS , FTI , GDDY , GDOT , GHDX , IAG , ICLR , INOV , IVR , JACK , KALU , LOPE , MANT , MMI , MSA , NDSN , NE , NTE...
Quick Take Charles River Laboratories ( CRL ) announced it has made a binding offer to acquire Citoxlab for about $510 million in cash (€448 million). Citoxlab operates as as a non-clinical contract research organization [CRO]. CRL is acquiring Citoxlab to expand its service off...
Developed on platform deploying rule-based automation for timely delivery of drug safety information ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the relea...
Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...
ICON PLC (NASDAQ: ICLR ) upgraded to Buy with a $150 (14% upside) price target at Mizuho. More news on: Icon PLC, Illumina, Inc., ResMed Inc., Healthcare stocks news, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading business and industry awards recognising the company’s leadership position in the clinical research industry, in addi...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second quarter 2024 after the market closes on Wednesday, July 24, 2024. The company will hold a conference call and webcas...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET. Any changes to this event and links...